financetom
Business
financetom
/
Business
/
Ideaya Biosciences Insider Sold Shares Worth $1,032,884, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ideaya Biosciences Insider Sold Shares Worth $1,032,884, According to a Recent SEC Filing
Jun 3, 2024 1:11 AM

03:56 AM EDT, 06/03/2024 (MT Newswires) -- Michael Anthony White, Chief Scientific Officer, on May 29, 2024, sold 28,500 shares in Ideaya Biosciences ( IDYA ) for $1,032,884.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1676725/000161071724000272/xslF345X03/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia surpasses $3.6 trillion market value after Trump win
Nvidia surpasses $3.6 trillion market value after Trump win
Nov 9, 2024
(Reuters) - Shares of Nvidia rallied to a record high on Thursday, making the chipmaker the first company in history to surpass a stock market value of $3.6 trillion as Wall Street extended a rally sparked by Donald Trump's return to the White House. The dominant AI chipmaker's shares rose 2.2%, lifted by broad investor optimism about tax cuts and...
California agency boosts reporting requirements for autonomous vehicle incidents
California agency boosts reporting requirements for autonomous vehicle incidents
Nov 9, 2024
Nov 7 (Reuters) - A California state agency said Thursday it is mandating enhanced data reporting requirements for autonomous vehicles including reports for incidents where self-driving cars get stuck. The California Public Utilities Commission (CPUC) is requiring companies to file detailed trip-level incident reports that cover both collision and non-collision incidents, including citations and stoppage events. In June, GM self-driving...
Solventum raises annual profit forecast on strong surgical product sales
Solventum raises annual profit forecast on strong surgical product sales
Nov 9, 2024
Nov 7 (Reuters) - 3M spin-off Solventum ( SOLV ) raised its annual profit forecast on Thursday, betting on strong sales of its wound care and surgical sterilization products. The company now expects annual adjusted profit in the range of $6.50 to $6.65 per share, compared to its previous estimate of $6.30 to $6.50 per share. Minnesota-based Solventum ( SOLV...
Expedia Group Q3 Adjusted Earnings, Revenue Rise; CFO Julie Whalen to Depart -- Shares Up
Expedia Group Q3 Adjusted Earnings, Revenue Rise; CFO Julie Whalen to Depart -- Shares Up
Nov 9, 2024
04:33 PM EST, 11/07/2024 (MT Newswires) -- Expedia Group ( EXPE ) reported Q3 adjusted earnings late Thursday of $6.13 per share, up from $5.41 a year earlier. Analysts surveyed by Capital IQ expected $6.12. Revenue for the quarter ended Sept. 30 was $4.06 billion, up from $3.93 billion a year earlier. Analysts surveyed by Capital IQ expected $4.11 billion....
Copyright 2023-2026 - www.financetom.com All Rights Reserved